![Amol Akhade: India made cervical cancer vaccine is non inferior to original made by MSD in phase 2/3 RCT](https://oncodaily.com/pub/uploads/2023/10/C09162A2-B197-4058-BC72-9F3D7EA79A9A.jpeg)
Photo taken from Amol Akhade/Twitter
Nov 29, 2023, 19:32
Amol Akhade: India made cervical cancer vaccine is non inferior to original made by MSD in phase 2/3 RCT
Amol Akhade, Consultant Medical Oncologist/Hematologist at Suyog Cancer Clinics, posted on Twitter:
“So India made cervical cancer vaccine ( Cervavac ) is non inferior to original made by MSD ( Gardasil ) in phase 2/3 RCT. It is less than Half as costly as Original. This will make cervical cancer vaccine more accessible and affordable, not only to LMICs but to HICs also.”
Source: Amol Akhade/Twitter